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A U-SHAPE RELATIONSHIP WAS FOUND WITH RE-GARD TO SLEEP DURATION AND OUTCOME STUDIES WHICH SHOWED THAT BOTH SHORT AND LONG SLEEP durations were associated with the risk of all-cause death among Caucasians, [1] [2] [3] Japanese, 4, 5 and Taiwanese. 6 However, the association between sleep duration and cardiovascular disease (CVD) risk was inconsistent: a U-shape relationship was found among Chinese in Singapore 7 and white women, 8 but other studies only showed an inverse relationship. 9 Short sleep duration has been linked to increased obesity and weight gain, [10] [11] [12] diabetes, 13 and hypertension 14, 15 ; and this association has been attributed to the relationship between sleep duration and all-cause death and CVD risk. However, the association between long sleep duration and CVD risk remains unexplained.
Ethnic difference for the risk of sleep duration and sleep quality, such as insomnia severity, has been reported. Ethnic and geographic variation in self-reported sleep duration has been noted. 16, 17 A nationwide survey of 32,749 adults aged 18 years or older in the United States showed that compared with Caucasians, African Americans and other non-Hispanics, including Asian Americans, were more likely to be short or long sleepers, and the relative risks ranged from 1.26 to 1.62. 16 In a population-based survey of 3,158 adults, the prevalence of reduced habitual sleep time was higher in African Americans than Caucasians (18.7% vs. 7.4%). 17 However, African Americans were less likely to have sleep complaints among a crosssectional study based on 13,563 adults aged 47 to 69 years. 18 Evidence regarding the prevalence and the risk of sleep duration among ethnic Chinese is relatively rare. 6, 19 Furthermore, the issues on association between sleep duration and the risk of all-cause death and CVD events need to sleep duration and CVD risk is still persistent after multivariate adjustment. Previous studies included only limited covariates in an adjusted model. Second, potential effect modbeen reported. 20 Third, insomnia severity was associated with CVD outcomes, [21] [22] [23] but its role with regards to all-cause death is still unknown. Therefore, we hypothesized that reduced or prolonged sleep duration and frequent insomnia predisposed individuals to increased risk of all-cause deaths and cardiovascular events. We tested this hypothesis using a large prospective cohort of middle-aged to older Chinese adults in a community in Taiwan.
HABITUAL SLEEP DURATION, INSOMNIA AND HEALTH RISK
Habitual Sleep Duration and Insomnia and the Risk of Cardiovascular Events and All-cause Death: Report from a Community-Based Cohort
METHODS

Study Design and Study Population
Participants in the Chin-Shan Community Cardiovascular Cohort study who completed questionnaires about lifestyle and sleep in 1990-1991 were the population for this study. Details of this cohort study have been published previously. [24] [25] [26] [27] [28] this study began in 1990 by recruiting 1,703 men and 1,899 was living in the Chin-Shan township 30 km north of metropolitan Taipei, Taiwan. Information about anthropometry, lifestyle, and medical conditions was assessed by interview questionnaires in 2-y cycles, and the validity and reproducibility of the collected data and measurements have been reported in detail elsewhere. 28 The National Taiwan University Hospital Committee Review Board approved the study protocol.
Exposure Measures
We measured sleep in 1990 with 2 self-reported variables: habitual sleep duration and insomnia severity. Sleep duration questionnaire for the frequency of insomnia complaints in the past one year were as follows: "How frequent is your insomnia complaint?" and the 4 response alternatives, including "no insomnia," "occasional insomnia (2-3 times each month)," "frequent insomnia (2-3 times each week)," and "insomnia nearly every day," were chosen. Participants were reminded that the asleep, staying asleep, or additional nonrefreshing sleep.
Biochemical and Clinical Measures
The procedures for blood sample collection were reported elsewhere. 29, 30 batch assay for levels of total cholesterol, triglycerides, and high density lipoprotein cholesterol (HDL-C). Standard enzymatic tests for serum cholesterol and triglycerides were used (Merck 14354 and 14366, Germany, respectively). HDL-C levels were measured in supernatants after the precipitation of specimens with magnesium chloride phospho tungstate reagents (Merck 14993). LDL-C concentrations were calculated as total cholesterol minus cholesterol in the supernatant using the precipitation method (Merck 14992).
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Outcome Ascertainment -ed coronary heart disease and stroke cases. Incident coronary -dial infarction, fatal coronary heart disease, and hospitalization due to percutaneous coronary intervention and coronary bypass surgery. Incident stroke cases (n = 246) were ascertained acof vascular origin that lasted longer than 24 h, with supporting neurologists and internists.
Statistical Analysis
Participants were categorized on the basis of sleep duration and insomnia severity, and the continuous variables were presented by mean and standard deviation, and ANOVA was used to test the difference across quartiles. Incidence rates of all-cause death and CVD event were calculated by dividing the number of cases by the person-years of follow-up for each category of sleep duration and insomnia severity. The Cox proportional hazards model was applied to estimate the -tion and insomnia status. All models were adjusted for age (in 10-y categories) and gender. Additional baseline covariates for which simultaneously adjusted covariates included body mass 2 ), smokno), marital status (single, married and living with spouse, or -vs. no), and family history of coronary heart disease. The third model included covariates in the additional model plus clinical level. The joint effects of sleep duration and insomnia severity were estimated in the multivariate Cox models. Here, insomnia was categorized as dichotomies, describing optimal (no or infrequent) versus nonoptimal (frequently or nearly everyday insomnia), and the duration of sleep was grouped into 3 strata -amined the non-linear relationship between sleep duration and risk of all-cause death and CVD events with restricted cubic splines. 32 the restricted cubic splines into the multivariate Cox model to examine the possible non-linear relationship between sleep duration as well as insomnia and relative risks of all-cause death the likelihood ratio tests for non-linearity, and the plot for the 32 We -mer and Lemeshow test, 33 ceptable (P Performance measures, including area under receiver operating (NRI) and integrated discrimination improvement (IDI), were used to compare the models with and without sleep variables, described in Supplementary Methods.
All statistical tests were 2-tailed, and probability values performed with SAS version 9.1 (SAS Institute, Cary, NC) and Stata version 9.1 (Stata Corporation, College Station, Texas).
RESULTS
After excluding missing data on sleep (n = 172), 3,430 participants were included in this study. The baseline characteristics of clinical, lifestyle, socioeconomic, and biochemical measures are listed in Table 1 , according to sleep duration and insomnia severity. Compared with those sleeping 7 or 8 h, participants and alcohol drinkers. Shorter and longer sleepers were older, having a longer nap time, and higher blood pressure and uric acid levels than those sleeping 7 or 8 h. Compared with those
Sleep and Death Risk-Chien et al with no or occasional insomnia complaints, participants with frequent nearly daily insomnia were more likely to be women, have cardiovascular disease and hypertension history, and less likely to be smokers, separated or divorced, and menopause; have habits of regular exercise and regular napping. Participants with frequent insomnia were older, had a lower body mass index, higher blood pressure, higher cholesterol, triglyceride, fasting glucose, and less nap time.
During a median 15.9 (interquartile range, 13.1 to 16.9) years' follow-up period, 420 cases developed cardiovascular disease and 901 cases died. The incidence rates, relative risks for allcause death and cardiovascular events are listed in Table 2 . A U-shape association between sleep duration and all-cause death was found: the age and gender-adjusted relative risks (95% CI) of all-cause death (with 7 h of daily sleep being considered the and 1.43 (1.16-1.75, P for trend, 0.019), respectively. After adjusting for various potential confounding factors, the relative sleep was 1.34 (1.08-1.67). The U-shape relationship between sleep duration and risk of all-cause death was also observed by splines method (Figure 1 In a joint analysis of sleep duration as well as insomnia severity and the risk of all-cause death and CVD (Figure 2 ), par--somnia had the highest risk for all-cause death and CVD risk, compared with those with sleeping 7 to 8 h and infrequent insomnia. The multivariate adjusted relative risk (95% CI) was 2.53 (1.71-3.76) for allcause death and 2.07 (1.11-3.85) for CVD -quent insomnia. 1 Among 82,969 women from the Nurses Health Study who were followed up for 14 years, A U-shape relationship between sleep duration and all-cause death was also found after multiple covariate adjustment. 2 Compared with women sleeping 7 h, women sleeping cause death. 2 However, the U-shape association was not found in Japanese women. [4] [5] Compared with those sleeping 7-8 h, women sleeping shorter than 6 h had a 0.7-fold (95% CI, 0.2-2.3) risk and women sleeping 9 h or longer had a 1.5-fold (95% CI, 1.0-2.4) risk for all-cause death.. 5 Furthermore, the association between sleep duration and all-cause death were observed only in elderly, but not in middle-aged adults. 3 Another cohort based on Scottish adults also showed only short sleep duration was associated with cardiovascular and all-cause death. 40 A cohort based on the nation-wide representative sample of 3079 Taiwanese adults 64 years and older who were followed for 10 h for women) was associated with the risk of all-cause death 6 : the multivariate risk was 1.42 (95% CI, 1.08-1.86 ) for men and We tested the performance measures for all-cause death and CVD risk with and without sleep duration and insomnia complaints in the multivariate models using AUC, NRI, and IDI statistics (Supplementary Table) . Adding sleep duration provided a modest improvement in predicting the risk of all-cause death and CVD beyond the standard risk factors by AUC measures (AUC, from 0.854 to 0.855 for all-cause death, from 0.741 to 0.740 for CVD event, P, 0.24 and 0.09) IDI values for all-cause death indicated that adding sleep duration information resulted in a better discrimination improvement (NRI, 2.0%, P, 0.023; IDI, 0.3%, P, 0.003). Sleep duration did not improve prediction for CVD events. Similarly, adding insomnia information results in a modest discrimination for all-cause death (IDI, 0.2%, P, 0.017) and CVD events (IDI, 0.2%, P 0.049).
DISCUSSION
In this cohort of middle-aged to older Chinese, habitual -ated with increased future risk of all-cause deaths. Longer sleep time and frequent or nearly everyday insomnia appeared to be a stronger predictor of all-cause death.
Previous studies have shown the consistency of long sleep duration for the risk of all-cause death.
1,2 A large population 8 demonstrated a U-shape association between sleep duration and the risk of coronary artery disease. For the risk of stroke, a prospective cohort based 93,175 postmenopausal women aged 50-79 y who were followed for 7.5 y showed a U-shape relationship between sleep duration and ischemic stroke risk. 41 The associations were stronger among women without prevalent cardiovascular disease at baseline. 41 However, our data did not support sleep duration as an independent predictor for CVD event after adjustment for extensive biochemical measurements. Therefore, we proposed that the underlying mechanistic mediators for the putative adverse effect of long sleep was mediated by clinical and biochemical measures. In fact, recent study on coronary as 6 to 8 h sleepers. 43 With regards to insomnia severity, our results are consistent with previous studies conducted in primarily Caucasian populations. In another cohort study based on 6896 adults aged 45 to 74 y in Augsburg city for a mean follow-up period of 10.1 y, sleep duration and sleep complaints were associated with risk of incident myocardial infarction, especially among women. 9 Moreover, poor sleep quality, such as daytime somnolence, was associated with a 1.9-fold (95% CI, 1.2-3.1) risk for stroke. 42 Frequent insomnia was associated with cardiovascular disease risk among 1986 British men aged 55-69 y for a 10-y follow-up duration. 21 Insomnia complaints predicted an increased risk of cardiovascular disease (relative risk, 1.5; 95% CI, 1.1-2.0) and hypertension (relative risk, 1.2; 95% CI, 1.03-1.3) in North American communities. 44 In our study, insomnia severity was as important as sleep duration in predicting cardiovascular disease risk, which was consistent with other studies. In addition, our study showed that increased mortality appeared restricted to those with both selfsuch as sleep apnea, periodic limb movement disorder, or systemic disease.
of sleep duration and risk of all-cause death and CVD events 2.26 (95% CI, 1.59-3.22) for women. The lack of U-shape relationship for this elderly Taiwanese cohort may be attributed to only one group < 7 h. 6 Our results did not support gender and all-cause death. With regards to cardiovascular events, the available evidence Singapore who were followed up for 13 y, both short and long sleep durations were associated with coronary artery disease mortality. 7 Compared with adults with a sleep duration of 7 h, the multivariate relative risk for a sleep duration of 5 h was 1.57 Sleep and Death Risk-Chien et al among ethnic Chinese. Evidence from other Asian populations also demonstrates that sleep duration and quality were associated with increasing risk events, but head-to-head comparison of sleep duration and insomnia severity has not been available. Because of the prospective cohort design, the baseline measurements of all cohort members were unlikely to be affected by storage and laboratory issues that might be raised in some nested case-control studies. The use of a community-based population could reduce the possibility of selection bias. We also included important socioeconomic, lifestyle, and clinical factors in the models to control the potential confounding factors. Previous studies did not include biochemical measures, which confounded the association with the outcomes. In addition, combining habitual sleep duration and insomnia complaints from self-reported data improved the prediction of all-cause death.
Our study had several potential limitations. First, because self-reported sleep duration and insomnia data were measured only once, our results might be attenuated by intra-individual variations. Self-reported sleep duration was used; no other objective measures (e.g., actigraphy) were used. Second, we did not include prescription sleeping pill dosage in our study because of limited medical records in this cohort. Previous studies showed prescription sleeping pill use was also associated with all-cause death.
1 Finally, our measure on self-reported insomnia severity is a measure of sleep quality, but does not include sleep apnea, restless legs syndrome, depression, or a multitude of other disorders. Insomnia is perceived as a symptom that could be associated with a variety of psychiatric and medical disorders. 45 ing and maintaining sleep or experiencing nonrefreshing sleep and is associated with daytime consequences. 46 Our study did
In conclusion, we clearly demonstrate that sleep duration and insomnia severity were associated with all-cause death and CVD events among ethnic Chinese in Taiwan. Our data indicates that optimal sleep duration (7-8 h) and infrequent insomnia predicted fewer CVD events and less death. Further studies are warranted to better understand the possible mechanisms for sleep duration and insomnia.
